Compare iShares MSCI Germany (DAX) (EWG) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs UnitedHealth Group Inc — how do they compare? iShares MSCI Germany (DAX) trades at $40.96 (market cap $1.42B), while UnitedHealth Group Inc trades at $379.3 (market cap $332.96B). The key difference: UnitedHealth Group Inc is far larger — about 234.5× iShares MSCI Germany (DAX)'s market cap, and UnitedHealth Group Inc pays a 2.5% dividend while iShares MSCI Germany (DAX) pays none. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Germany (DAX) for 54 Days and UnitedHealth Group Inc for 97 Days on average.
| EWG | UNH | |
|---|---|---|
Market Cap | $1.42B | $332.96B |
Volume | 1,110,573 | 7,273,749 |
Sector | Broad Market / Factor | Health |
52-Week High | $44.59 | $436.35 |
52-Week Low | $38.08 | $259.02 |
Typical Hold Time | 54 Days | 97 Days |
Enterprise Value | — | $374.82B |
Dividend Yield | — | 2.5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG trades at $40.96 with minimal daily movement (+0.12%). Technical indicators show a bearish trend with strong selling pressure across moving averages and oscillators, though RSI levels suggest potential oversold conditions. The stock faces resistance at $41 with support at $40. Recent European market news highlights mixed sentiment with resilient equities but concerns about ECB rate hikes and energy-driven inflation pressures.
The outlook remains cautious due to bearish technicals and macroeconomic headwinds from potential ECB tightening. Investment opportunity exists if oversold RSI levels trigger a rebound, but risks include further rate hikes and energy price volatility. Stock performance hinges on European economic stability and inflation control.
UnitedHealth Group (UNH) trades at $370.95, down 1.34% on the day, amid a bearish technical signal from moving averages. The company reported strong Q2 2026 earnings, beating estimates with EPS of $6.38 versus $4.91 expected, and raised full-year guidance. Revenue for 2025 reached $447.57 billion, though net income margin declined to 2.69%. Analyst consensus remains strongly bullish with an 82.69% buy rating and a $470.11 price target, suggesting significant upside from current levels.
UNH presents a compelling investment case driven by earnings beats, raised 2026 outlook, and strategic initiatives like AI investment in Optum. Key risks include regulatory pressures in healthcare, volatility from Medicare Advantage plan changes, and margin compression. The stock's valuation at a P/E of 23.84 appears reasonable given growth prospects, but investors should weigh execution risks against the positive analyst sentiment and institutional backing.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
